James A. Turpin - Frederick MD, US Yongsheng Song - East Haven CT, US Ettore Appella - Chevy Chase MD, US John K. Inman - Bethesda MD, US David G. Covell - Chevy Chase MD, US William G. Rice - Madison CT, US Anders Wallqvist - Frederick MD, US Andrew Maynard - Wilmington DE, US Mingjun Huang - Rockville MD, US
International Classification:
A61K 31/435 A61K 39/12
US Classification:
514277, 546 1, 546298, 435 5, 4242041, 514706
Abstract:
This invention pertains to the discovery of a novel family of thiolesters and uses thereof. Also provided for are viricidal compounds and pharmaceutical formulations comprising these novel thiolesters. The invention also provides thiolester-inactivated viruses and thiolester-complexed viral proteins.
Isothiazoloquinolones And Related Compounds As Anti-Infective Agents
Barton James Bradbury - Wallingford CT, US Godwin Pais - Hamden CT, US Qiuping Wang - Bethany CT, US Milind Deshpande - Madison CT, US Michael Pucci - Kensington CT, US Yongsheng Song - Guilford CT, US Edlaine Lucien - New Haven CT, US Jason Allan Wiles - Hamden CT, US Akihiro Hashimoto - Branford CT, US
Assignee:
Achillion Pharmaceuticals, Inc. - New Haven CT
International Classification:
A61K 31/4365 A61K 31/4375 C07D 491/14
US Classification:
514293, 546 83
Abstract:
The invention provides certain compounds and salts of Formula I and Formula II:.
8A,9-Dihydro-4Ah-Isothiazolo[5,4-B]Quinoline-3,4-Diones And Related Compounds As Anti-Infective Agents
Barton Bradbury - Wallingford CT, US Milind Deshpande - Madison CT, US Michael Pucci - Kensington CT, US Qiuping Wang - Bethany CT, US Jason Wiles - Hamden CT, US Yongsheng Song - Guilford CT, US Akihiro Hashimoto - Branford CT, US Edlaine Lucien - New Haven CT, US
International Classification:
A61K 31/496 A61K 31/4745 C07D 498/02
US Classification:
514253030, 514291000, 544361000, 546083000
Abstract:
The invention provides compounds and salts of Formula I and Formula II: which possess antimicrobial activity. The invention also provides novel synthetic intermediates useful in making compounds of Formula I and Formula II. The variables n, m, p, R, R, A, R, R, R, R, R, Aand Rare defined herein. Certain compounds of Formula I and Formula II disclosed herein are potent and/or selective inhibitors of bacterial DNA synthesis and bacterial replication. The invention also provides antimicrobial compositions, including pharmaceutical compositions, containing one or more compounds of Formula I or Formula II and one or more carriers, excipients, or diluents. Such compositions may contain a compound of Formula I or Formula II as the only active agent or may contain a combination of a compound of Formula I or Formula II and one or more other active agents. The invention also provides methods for treating microbial infections in eukaryotes.
Yongsheng Song - Guilford CT, US Yongchun Hou - Mentor OH, US Sandeep Gupta - Concord OH, US Aimee Reed - Willoughby OH, US Debasis Ghosh - Perrysburg OH, US
International Classification:
A61K 31/519 C07D 487/02
US Classification:
514264100, 544250000, 544279000, 514267000
Abstract:
Disclosed herein are pyrido[2,3-d]pyrimidines having the structure
New Isothiazoloquinolones And Related Compounds As Anti-Infective Agents
Barton James Bradbury - Wallingford CT, US Godwin Pais - Hamden CT, US Quiping Wang - Bethany CT, US Milind Deshpande - Madison CT, US Michael Pucci - Kensington CT, US Yongsheng Song - Guilford CT, US Edlaine Lucien - New Haven CT, US Jason Allan Wiles - Hamden CT, US Akihiro Hashimoto - Branford CT, US
The invention provides certain compounds and salts of Formula I and Formula II:which possess antimicrobial activity. The invention also provides novel synthetic intermediates useful in making compounds of Formula I and Formula II. The variables A, R, R, R, R, R, Aand Rare defined herein.Certain compounds of Formula I and Formula II disclosed herein are potent and selective inhibitors of bacterial DNA synthesis and bacterial replication. The invention also provides antimicrobial compositions, including pharmaceutical compositions, containing one or more compounds of Formula I or Formula II and one or more carriers, excipients, or diluents. Such compositions may contain a compound of Formula I or Formula II as the only active agent or may contain a combination of a compound of Formula I or Formula II and one or more other active agents. The invention also provides methods for treating microbial infections in animals.
Different components of natural oils are separated by forming solid complexes of components of the natural oil with a solvent, and then separating the solid complexes from the remaining liquids. The natural oil is cooled in the presence of a solvent, and at least one component of the oil forms the solid complex with the solvent. This solid complex is separated from the remaining liquid portion of the oil solution, which also contains the solvent. Additional options concentration steps can further concentrate the components left in the liquid phase.
James A. Turpin - Frederick MD Yongsheng Song - East Haven CT Ettore Appella - Chevy Chase MD John K. Inman - Bethesda MD David G. Covell - Chevy Chase MD William G. Rice - Madison CT Anders Wallqvist - Frederick MD Andrew Maynard - Wilmington DE Mingjun Huang - Rockville MD
Assignee:
The United States of America as represented by the Department of Health and Human Services - Washington DC
International Classification:
A61K 3144
US Classification:
514298, 514354, 514355, 546298
Abstract:
This invention pertains to the discovery of a novel family of thiolesters and uses thereof. Also provided for are viricidal compounds and pharmaceutical formulations comprising these novel thiolesters. The invention also provides thiolester-inactivated viruses and thiolester-complexed viral proteins.
Different components of natural oils are separated by forming solid complexes of components of the natural oil with a solvent, and then separating the solid complexes from the remaining liquids. The natural oil is cooled in the presence of a solvent, and at least one component of the oil forms the solid complex with the solvent. This solid complex is separated from the remaining liquid portion of the oil solution, which also contains the solvent. Additional options concentration steps can further concentrate the components left in the liquid phase.
Name / Title
Company / Classification
Phones & Addresses
Yongsheng Song manager
Ceucos LLC DEALINGS IN PERSONAL CARE AND COSCEUTICALS
Madison, AL 35758
Yongsheng Song
CR4PHARMA, LLC
Googleplus
Yongsheng Song
About:
平常 平和 平实 平安
Bragging Rights:
从学校毕业----参军当兵------转业工作-----退休养老
Yongsheng Song
Youtube
- () Lotus Heart Song - Jing Shanyuan (Yang ...
"... ... (... "Lotus Heart Song" in...
Duration:
4m 29s
Snipers 2022 Movie The tribute song - Zhang J...
_ Snipers ... _ _ "Sniper" - Snipers Zhang Jie sang the tribute song...
Duration:
3m 44s
Tibetan chinese song- people of Qinghai-Tibet...
tibet China song.
Duration:
4m 17s
Hokkien Song - Yong Sheng Ming Suo Ai De Ren
Please DON'T REUPLOAD any videos at this channel!!! Respect to the sin...
Duration:
3m 16s
Tibetan Song Yadon Kunga Tsewang and Gangshuk
"A MENTAL RETURN" is my translation of this beautiful and inspiring so...